The gene encodes a component of the NADPH oxidase complex and these studies catalyzed the development of a new therapy for arthritis, based on the use of oxidative-burst inducing substances [43–45] (see Table 1B, Arthritis, Ncf1 gene). The gene discussed is FMO5; the disease is arthritic joint disease.